Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients

By Cheng K.K.F.   Molassiotis A.   Chang A.M.   Wai W.C.   Cheung S.S.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2056-2063

Elsevier

Access to resources Recommend Favorite

Therapeutic Equivalence of Single Oral Doses of Dolasetron Mesilate and Multiple Doses of Ondansetron for the Prevention of Emesis After Moderately Emetogenic Chemotherapy

By European Dolasetron Comparative Study Group   Fauser A.A.   Duclos B.   Chemaissani A.   Del Favero A.   Cognetti F.   Diaz-Rubio E.   Cortes-Funes H.   Conte P.F.   Dressler H.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1523-1529

Elsevier

Access to resources Recommend Favorite

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

By Awidi A.   Homsi U.   Kakail R.I.   Mubarak A.   Hassan A.   Kelta M.   Martinez P.   Sulaiti S.   Al Qady A.   Jamhoury A.   Daniel M.   Charles C.   Ambrose A.   El-Aloosy A.S.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2010-2014

Elsevier

Access to resources Recommend Favorite

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer

By Navari Rudolph M  

Future Oncology, Vol. 6, Iss. 7, 2010-07 ,pp. : 1073-1084

Future Medicine

Access to resources Recommend Favorite